KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Change in Accured Expenses (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Change in Accured Expenses data on record, last reported at $112.9 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 196.25% year-over-year to $112.9 million; the TTM value through Dec 2025 reached $101.8 million, up 131.61%, while the annual FY2025 figure was $101.8 million, 131.61% up from the prior year.
  • Change in Accured Expenses reached $112.9 million in Q4 2025 per ZBH's latest filing, up from -$51.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $164.2 million in Q4 2023 and bottomed at -$138.3 million in Q1 2021.
  • Average Change in Accured Expenses over 5 years is -$4.3 million, with a median of -$28.6 million recorded in 2022.
  • Peak YoY movement for Change in Accured Expenses: crashed 477.36% in 2023, then soared 223.67% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $64.0 million in 2021, then surged by 63.44% to $104.6 million in 2022, then soared by 56.98% to $164.2 million in 2023, then crashed by 171.44% to -$117.3 million in 2024, then skyrocketed by 196.25% to $112.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $112.9 million in Q4 2025, -$51.5 million in Q3 2025, and $76.8 million in Q2 2025.